CYP2C8 and breast carcinoma: This is not fully compatible with our finding, as we found both a higher frequency of nodal involvement with the CYP2C8/9 *3/*1/*2/*1 genotype (in tumours larger than 20 mm) and a higher risk of any type of breast cancer recurrence, especially in women treated with tamoxifen.